It's the final episode of season 2!
We continue our conversation with Ms Tanaka, who is a Strategy and Consulting Senior Analyst at Pfizer. In this episode, she discusses how her experience running a multicultural organization at Duke University has helped her develop initiatives at Pfizer to encourage diversity with regards to clinical trials for higher drug and vaccine efficiency. She also shares advice for college level students in building a concrete network.
